Trial Profile


Phase of Trial: Phase III

Latest Information Update: 21 Apr 2009

At a glance

  • Drugs Ethyl eicosapentaenoic acid (Primary)
  • Indications Huntington's disease
  • Focus Registrational; Therapeutic Use
  • Acronyms TREND-EU
  • Most Recent Events

    • 21 Apr 2009 New trial record.
    • 09 Apr 2009 Marketing Authorization Application has been accepted for review by the European Medicines Agency, according to a Amarin Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top